Case Study: a leading life sciences company modernizes bioreactor controls and avoids $900K+ in costs with Catalyx OpenBIO

Leading Life Sciences Company - Customer Case Study

A leading life sciences company faced significant operational risks when Cytiva discontinued support for its aging Siemens-based bioreactor control systems. Without in-house expertise and reliant on unsupported legacy components, the client was vulnerable to costly downtime and initially anticipated a full, expensive system replacement. They turned to Catalyx for a modernization solution that would ensure GMP compliance and minimize disruption.

Catalyx implemented its OpenBIO open architecture bioreactor controller to modernize the systems while reusing key existing components. This approach, completed in just three days, saved the client over $900,000 by avoiding a full replacement and ensured effortless GMP compliance. Catalyx provided comprehensive training, which enhanced the client's operational autonomy and eliminated their reliance on external integrators.